Literature DB >> 11563200

Chemotherapy for older women with node-positive breast cancer.

D Ginsburg.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11563200      PMCID: PMC81402     

Source DB:  PubMed          Journal:  CMAJ        ISSN: 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  8 in total

1.  Hormonal versus chemohormonal adjuvant therapy in node-positive postmenopausal patients.

Authors:  A U Haq; M B Haq
Journal:  J Clin Oncol       Date:  1990-11       Impact factor: 44.544

2.  Effectiveness of adjuvant chemotherapy in combination with tamoxifen for node-positive postmenopausal breast cancer patients.

Authors: 
Journal:  J Clin Oncol       Date:  1997-04       Impact factor: 44.544

3.  Clinical practice guidelines for the care and treatment of breast cancer: adjuvant systemic therapy for node-positive breast cancer (summary of the 2001 update). The Steering Committee on Clinical Practice Guidelines for the Care and Treatment of Breast Cancer.

Authors:  M Levine
Journal:  CMAJ       Date:  2001-03-06       Impact factor: 8.262

4.  Epirubicin plus tamoxifen versus tamoxifen alone in node-positive postmenopausal patients with breast cancer: A randomized trial of the International Collaborative Cancer Group.

Authors:  J A Wils; J M Bliss; M Marty; G Coombes; C Fontaine; F Morvan; T Olmos; F R Pérez-López; P Vassilopoulos; E Woods; R C Coombes
Journal:  J Clin Oncol       Date:  1999-07       Impact factor: 44.544

5.  Postoperative chemotherapy and tamoxifen compared with tamoxifen alone in the treatment of positive-node breast cancer patients aged 50 years and older with tumors responsive to tamoxifen: results from the National Surgical Adjuvant Breast and Bowel Project B-16.

Authors:  B Fisher; C Redmond; S Legault-Poisson; N V Dimitrov; A M Brown; D L Wickerham; N Wolmark; R G Margolese; D Bowman; A G Glass
Journal:  J Clin Oncol       Date:  1990-06       Impact factor: 44.544

6.  Systemic adjuvant therapy in treatment of primary operable breast cancer: National Surgical Adjuvant Breast and Bowel Project experience.

Authors:  B Fisher; C Redmond; E R Fisher; N Wolmark
Journal:  NCI Monogr       Date:  1986

7.  Randomised trial of chemo-endocrine therapy, endocrine therapy, and mastectomy alone in postmenopausal patients with operable breast cancer and axillary node metastasis.

Authors: 
Journal:  Lancet       Date:  1984-06-09       Impact factor: 79.321

8.  Polychemotherapy for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group.

Authors: 
Journal:  Lancet       Date:  1998-09-19       Impact factor: 79.321

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.